V
Verona Pharma plc D
D
VRNA
75.080
USD
2.46
(3.39%)
مغلق
حجم التداول
27,532
الربح لكل سهم
-0
العائد الربحي
-
P/E
-38
حجم السوق
6,391,710,785
الأخبار المقالات
العنوان: Verona Pharma plc
القطاع: Healthcare
الصناعة: Biotechnology
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.